BEONE MEDICINES LTD. Proceeds from Common Stock Issued
BEONE MEDICINES LTD. (ONC) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-02-26
- BEONE MEDICINES LTD. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for the quarter ending 2021-09-30 was $50.00M, a 97.58% decline year-over-year.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for the quarter ending 2021-06-30 was $0.00.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for fiscal 2023 was $0.00.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for fiscal 2021 was $50.00M, a 98.82% decline from fiscal 2020.
- BEONE MEDICINES LTD. proceeds from issuance of common stock for fiscal 2020 was $4.23B.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-26 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $50.00M derived: sum of 2 quarters · filed 2024-02-26 | $50.00M derived: sum of 3 quarters · filed 2024-02-26 | $50.00M 10-K · filed 2024-02-26 |
| 2021-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $50.00M derived: sum of 2 quarters · filed 2022-11-09 | $50.00M 10-Q · filed 2022-11-09 | $50.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $2.07B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $2.07B derived: sum of 3 quarters · filed 2023-02-27 | $2.07B derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.07B derived: sum of 2 quarters · filed 2023-02-27 | $2.07B derived: sum of 3 quarters · filed 2023-02-27 | $4.23B 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.07B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.07B derived: sum of 2 quarters · filed 2021-11-04 | $4.23B 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.16B 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $2.16B 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $149.93M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $149.93M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |